InsidersTradesSigma
H. Lundbeck A/S: directors' dealings · Denmark · Finanstilsynet DK
DK:h-lundbeck-asDK0061804697DK·Finanstilsynet DKMcap 39.8Bn€Healthcare
Explore the full directors' dealings record of H. Lundbeck A/S, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare sector, H. Lundbeck A/S has published 63 insider filings. Market capitalisation: €39.8bn. The latest transaction was disclosed on 16 February 2024 — Purchase. Among the most active insiders: Unknown. All data is free.
63
Insider Decl.
0
Thresholds
€923,063
30 ops.
Buy Volume
€18m
17 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
40.14 €
Analyst consensus
12 analystsBuy
34.00 €Target 47.21 €(+18%)65.00 €
Income statement
Revenue24.63 Bn€
Gross profit20.36 Bn€83% margin
Net income3.19 Bn€14.6% margin
Valuation
PER (trailing)10.7x
PER (forward)6.6x
P/Book1.6x
Beta0.26
Balance sheet & cash
Market cap39.82 Bn€
Total debt11.65 Bn€
Free Cash Flow4.86 Bn€
Debt / Equity43%
Profitability & ownership
ROE14.9%
ROA7.5%
% insiders0.1%
% institutions79.2%
Last declaration on 16 February 2024
Declarations0 total
No declarations found
0 of 0 declarations
About H. Lundbeck A/S
H. Lundbeck A/S is a Danish pharmaceutical company focused on developing treatments for psychiatric and neurological disorders. It emphasizes innovation in medications for conditions such as depression and schizophrenia.